Dr. Reddy's Laboratories Ltd. ADR buy HSBC Holdings plc
Start price
05.06.25
/
50%
€13.80
Target price
05.06.26
€14.80
Performance (%)
-18.84%
End price
06.06.26
€11.20
Summary
This prediction ended on 06.06.26 with a price of €11.20. The price of Dr. Reddy's Laboratories Ltd. ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -18.84%. HSBC_Holdings_plc has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Dr. Reddy's Laboratories Ltd. ADR | -5.556% | -5.556% | -17.742% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by HSBC_Holdings_plc for this prediction
In the thread Dr. Reddy's Laboratories Ltd. ADR diskutieren
Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $16.90 price target on the stock, up previously from $14.44.
Ratings data for RDY provided by MarketBeat
In the thread Trading Dr. Reddy's Laboratories Ltd. ADR
Die von HSBC_Holdings_plc gewählte maximale Laufzeit wurde überschritten